Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY - Get Free Report)'s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $24.31, but opened at $23.33. Daiichi Sankyo shares last traded at $23.77, with a volume of 108,076 shares trading hands.
Wall Street Analyst Weigh In
Separately, Nomura Securities upgraded shares of Daiichi Sankyo to a "strong-buy" rating in a research report on Friday, June 6th.
View Our Latest Report on DSNKY
Daiichi Sankyo Stock Performance
The company has a debt-to-equity ratio of 0.06, a current ratio of 2.53 and a quick ratio of 1.85. The firm has a market capitalization of $45.52 billion and a P/E ratio of 23.33. The stock's 50 day moving average is $24.15 and its two-hundred day moving average is $24.55.
Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $0.30 EPS for the quarter. Daiichi Sankyo had a net margin of 15.65% and a return on equity of 17.92%. The business had revenue of $3.40 billion during the quarter. As a group, equities analysts anticipate that Daiichi Sankyo Co., Ltd. - Sponsored ADR will post 0.73 earnings per share for the current fiscal year.
Daiichi Sankyo Company Profile
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
